Interferon plus Chinese herbs are associated with higher sustained virological response than interferon alone in chronic Hepatitis C: A meta-analysis of randomised trials

Antiviral Research

Volumn 89, Issue 2, 2011, Pages 156-164

  Zhao, Sihai ^a   Liu, Enqi ^a   Wei, Kena ^a   Lu, Shemin ^a   Chu, Yonglie ^a   Li, Yafeng ^a   Wang, Yanli ^a   Huang, Bingqiao ^a   Chen, Yulong ^a   Yang, Penghui ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chinese herbs; Chronic hepatitis C; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA1 INTERFERON; ALPHA2B INTERFERON; CHISHAO; DANGGUI; GLYCYRRHIZIC ACID DERIVATIVE; HEPATITIS B VACCINE; HERBACEOUS AGENT; HUAGQIN; HUANGQI; HUZZHANG; INTERFERON; JIANPI QINGHUA; LIGANLING; LINGZHI; NINJINYOEITO EXTRACT; OXYMATRINE; PEGINTERFERON ALPHA2A; PLANT MEDICINAL PRODUCT; RIBAVIRIN; SALVIA MILTIORRHIZA EXTRACT; SHESHECAO; THYMOSIN ALPHA1; UNCLASSIFIED DRUG; UNINDEXED DRUG; WUWEIZI; XIAOCHAIHU; YINCHEN; YIQI YANGGAN; ZHIZI;

ANEMIA; ARTICLE; CHINESE MEDICINE; DEPRESSION; DRUG SAFETY; DYSPNEA; FATIGUE; FEVER; HEADACHE; HEPATITIS C; HUMAN; INSOMNIA; META ANALYSIS; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MIDDLE AGED; PLANTS, MEDICINAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 78751613103     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.12.003     Document Type: Article

References (44)

1. Barnes P.M., Powell-Griner E., McFann K., Nahin R.L. Complementary and alternative medicine use among adults: United States, 2002. Adv. Data 2004, 27:1-19.
2. Chang Z.J., Li J.T. Clinical study on chronic hepatitis C treated with Yiqiyanggan Fang combining IFN α-2b and ribavirin. Chin. J. Liver Dis. (electronic version) 2009, 1:24-27.
3. Chen M.F., Zhu Z.H., Chen C.H., Gao X.C. ClinicaI effect of interferon α-2b combined with injectable oxymatrine in the treatment of chronic Viral hepatitis C. Chin. J. Prim. Med. Pharm. 2005, 12:387-388.
4. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7:177-188.
5. Di Bisceglie A.M., Hoofnagle J.H. Optimal therapy of hepatitis C. Hepatology 2002, 36:S121-S127.
6. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
7. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., Kessler R.C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575.
8. Falck-Ytter Y., Kale H., Mullen K.D., Sarbah S.A., Sorescu L., McCullough A.J. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann. Intern. Med. 2002, 136:288-292.
9. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Gonçales F.L., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002, 347:975-982.
10. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
11. Hadziyannis S.J., Sette H., Morgan T.R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P.J., Lin A., Ackrill A.M. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 2004, 140:346-355.
12. Han Z.Q. The discussion of α-2b interferon combined with oxymatrine for treatment of children's chronic hepatitis C. J. Med. Forum 2005, 26:60-61.
13. Hong N., Zheng J., Xu S.F., Chen S.M., Chen X.F. Clinical study on treating chronic C hepatitis with prescription No.1 for anti-hepatitis C. J. Fujian Coll. Tradit. Chin. Med. 2004, 14:10-11.
14. Jiang, J., 2007. Unpublished master's thesis. Central South University, Changsha, China.
15. Jing Y.F., Jing Y.Y., Wang T.Y., Li C.Y. Interferon α-2b combined with Xiaochaihu decoction for treatment of 18 cases of chronic hepatitis C. Chin. J. Integr. Tradit. West Med. Liver Dis. 2002, 12:111-112.
16. Kjaergard L.L., Villumsen J., Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann. Intern. Med. 2001, 135:982-989.
17. Kong S.L., Li Z.G., Sun L.X. The effect of acupoint injection and oxymatrine combined therapy in the treatment of chronic hepatitis C. Chin. J. Misdiagn. 2008, 8:7586-7587.
18. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
19. Li X.X., Xiao H.Q., Luo R.Y. Treatment of chronic hepatitis C by Jianpi Bushen therapy: a clinical observation of 20 cases. N. J. Tradit. Chin. Med. 2006, 38:33-35.
20. Li Y., Chen J.J., Chen Y.F., Wang Y., Zhang W., Xing L.J. Clinical study of kurorinone injection combined with syndrome differentiation of TCM to treat chronic hepatitis C. Chin. J. Integr. Tradit. West Med. Liver Dis. 2007, 17:335-336.
21. Li Y.D., Chen J.J. Clinical observation of oxymatrine injection for treatment of 18 cases of chronic hepatitis C. J. Shandong Univ. Tradit. Chin. Med. 2005, 29:125-126.
22. Liang T.J., Rehermann B., Seeff L.B., Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 2000, 132:296-305.
23. Lin X.C. Interferon combined with oxymatrine for treatment of 21 cases of chronic hepatitis C. Mod. Tradit. Chin. Med. 2006, 26:35-36.
24. Liu G.W., Zhao W.X., Ma S.P., Wang C.F. Traditional Chinese medicine and western medicine combined therapy for 34 cases of chronic hepatitis C. Henan Tradit. Chin. Med. 2008, 28:35-36.
25. Ma X.Y. Therapeutic effect of chronic hepatitis by using xiaochaihu decoction combined with interferon. J. Liaoning Univ. Tradit. Chin. Med. 2008, 10:106-107.
26. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358:958-965.
27. Meng S.X., Zhao W.X., Zhang Z.L., Ma S.P., Liu J.K. The effect of Jianpi Qinghua prescription in combination with interferon-alpha and ribavirin in the treatment of chronic hepatitis C. Guangming J. Chin. Med. 2010, 25:834-836.
28. Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., Tugwell P., Klassen T.P. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998, 352:609-613.
29. Motoo Y., Mouri H., Ohtsubo K., Yamaguchi Y., Watanabe H., Sawabu N. Herbal medicine Ninjinyoeito ameliorates ribavirin-induced anemia in chronic hepatitis C: a randomized controlled trial. World J. Gastroenterol. 2005, 11:4013-4017.
30. Niu G.L., Mai G.F., Li Z.L. Clinical study on chronic hepatitis C treated with Yigan Yin. Liaoning J. Tradit. Chin. Med. 2008, 35:1679-1680.
31. Saydah S.H., Eberhardt M.S. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J. Altern. Complement Med. 2006, 12:805-812.
32. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.
33. Sun X.H., Gao Y.Q., Wang L.T., Chen J.J. Clinical study on chronic hepatitis C treated by " liver-clearing granule" Shanghai J. Tradit. Chin. Med. 2003, 37:20-22.
34. Wang B.E. Management of chronic Hepatitis B: treatment of chronic liver diseases with traditional Chinese medicine. J. Gastroenterol. Hepatol. 2000, 15 (Suppl.):E67-70.
35. Wang J.K., Chai Y.P. Chinese medicine combined with Western medicine for treatment of 246 cases of severe chronic hepatitis C. Guangming J. Chin. Med. 2009, 24:98-99.
36. Wu W.F., Sun W.W. Analysis of the effect of α-2b interferon combined with compound glycyrrhizin for treatment of 30 cases of severe chronic hepatitis C. J. Clin. Hepatol. 2003, 6:228-229.
37. Wu Y.N., Sun K.W., Peng J.P., Chen B., Huang Y.H. Shugan Lipi tablet in combination with interferon-alpha and ribavirin in the treatment of chronic hepatitis C. Chin. J. Integr. Tradit. West Med. Liver Dis. 2009, 19:76-77.
38. Xiao H.Q., Luo R.Y., Wu W.F., Deng T.T. Observation of the effect of Jianpi Huoxue prescription for treatment of 32 cases of chronic hepatitis C. N. J. Tradit. Chin. Med. 2005, 37:46-47.
39. Xu M., Hua N., Luo L.T. Liganling combined with interferon for treatment of 26 cases of children's chronic hepatitis C. Chin. J. Integr. Tradit. West Med. Liver Dis. 2001, 11:233-234.
40. Yamashiki M., Nishimura A., Nobori T., Nakabayashi S., Takagi T., Inoue K., Ito M., Matsushita K., Ohtaki H., Kosaka Y. In vitro effects of sho-saiko-to on production of granulocyte colony-stimulating factor by mononuclear cells from patients with chronic hepatitis C. Int. J. Immunopharmacol. 1997, 19:381-385.
41. Yin J., Zeng H.M., Xue B.Y., Huang Z.H. Clinical study of Bingganning granule for treatment of chronic hepatitis C. J. Nanjing Tradit. Chin. Med. Univ. (Nat. Sci.) 2002, 18:21-23.
42. Yin M.S., Piao H.X., Han X.J., Jin R.X. Treatment of chronic hepatitis C with Kurorinone injection in combination with interferon α. Chin. J. Integr. Tradit. West Med. Liver Dis. 2004, 14:202-203.
43. Zhang F.S. Traditional Chinese medicine and western medicine combined therapy for 30 cases of chronic hepatitis C. Tradit. Chin. Med. Res. 2009, 22:27-28.
44. Zhou M., Xue B.Y., Li C.T., Wu M.H., Zhou S.S., Zhan Z.Q., Yin J., Yang Z.J. Clinical investigation on treatment of chronic hepatitis C with compound Chinese medicine Bingganning. J. Nanjing Tradit. Chin. Med. Univ. (Nat. Sci.). 2001, 17:283-286.